Cellgen Diagnostics

medical devices

About

Cellgen is developing a bio-fluid based molecular diagnostic that will serve as a therapeutic guidance platform for cancer patients. The platform incorporates machine learning to deliver intelligent, quantitative and actionable results to oncologists in under 5 hours. Designed to detect all DNA and RNAs, Cellgen's platform features a proprietary on-chip enrichment and detection workflow perfectly suited to be installed as the premier Companion Diagnostic testing system within leading oncology clinics. Running on Cellgen's proprietary platform, each disposable assay will yield inclusion / exclusion data, while also leveraging proprietary machine learning algorithms to intelligently monitor and predict therapeutic response. This information will help inform patients, physicians, and others on how best to simplify and optimize life-saving clinical protocols.

Technologies

Outlook GoDaddy Hosting Amazon AWS WordPress.org Google Font API Apache Vimeo Mobile Friendly

Keywords

medical equipment manufacturing medical and diagnostic laboratories predictive analytics immuno-oncology companion diagnostics biotech startup cancer therapy response non-amplification detection services biotech innovation real-time diagnostics disposable cartridge sample enrichment machine learning in diagnostics autoimmune disease monitoring autoimmune and inflammation tests rna transcriptome analysis biomarker signature analysis biomarker signature evaporating droplet technique immuno-oncology diagnostics healthcare technology machine learning algorithms genomic testing diagnostic technology biomarker-based therapy guidance rna-based diagnostics point-of-care molecular testing rna transcriptome profiling molecular diagnostics personalized medicine

Location

7545 Irvine Center Drive, Irvine, California, United States, 92618

Related Companies

Companies in the same industry